DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Gianni L, Romieu GH, Lichinitser M.
AVEREL: a randomized phase III trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer.
J Clin Oncol 2013;
31: 1719-1725
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.